Navigation Links
,,Alternative Therapy in HIV Patients

As more HIV-infected patients turn to complementary and alternative medicine, researchers have set out to determine the prevalence and factors associated with such use.

In this study, researchers evaluated CAM use among nearly 3,000 patients enrolled in the HIV Cost and Services Utilization Study. Using this sample of patients who received conventional HIV care, researchers determined demographic and clinical characteristics of people with HIV. Approximately six months later, the use of CAM was determined during a follow-up// survey..
Researchers used data from interviews and surveys to determine the prevalence of CAM use, CAM use with potential for adverse effects, and CAM use as a substitute for conventional HIV therapy.
Results show 53 percent of patients reported using at least one type of CAM during the course of the study. The four most commonly used methods were relaxation, spiritual healing, self-help and herbal medicine. More than one-fourth of the patients used CAM with the potential for side effects and 3 percent reported using CAM in lieu of conventional HIV therapy. More than one-half of the patients using CAM had not discussed it with their health care providers. Findings from the study show HIV-infected patients who desired medical information and involvement in medical decision-making were most likely to use CAM. Researchers suggest a need for a health care setting that encourages open discussion between health care providers and patients. They say, "Improved physician understanding about patients' need for control over their own health care and the benefits and risks of CAM in HIV care may open channels of communication."

Researchers conclude that with one quarter of HIV-infected patients using CAM at the risk of potential side affects, physicians should openly ask their patients about such use. They suggest displaying a nonjudgmental attitude toward CAM may encourage patients to accurately report their use , thereby preventing unnecessary adverse effects.

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:

(Date:12/1/2015)... Wilmington, Delaware (PRWEB) , ... December 01, 2015 ... ... award winner at the 7th Annual 2015 Golden Bridge Business Awards under the ... is a zero capex web based sample management software that ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... quantification and optimization of adjunctive imaging is the focus of numerous abstracts accepted ... meeting, November 29-December 4, 2015. Nine abstracts highlight the use of Volpara ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Excellence (BHCOE) today announced that the organization has awarded Education and Developmental Therapies ... a Distinguished Award. The award celebrates exceptional special needs providers that excel in ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... ... ... With FCPX Overlay: Grit , users can apply a grit effect ... truly endless, all with a click of a mouse. Each user has full control ... of field and more, all within Final Cut Pro X. , With FCPX Overlay: ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , 1 de diciembre de 2015 /PRNewswire/ ... para cuchillas de precisión, develó hoy un ... identidad de marca. El nuevo logo destaca ... y la ingeniería de productos con cuchillas ... ...
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology: